In vivo Tolerance to Lipopolyssacharides of Vaccine and Virulent Yersinia pestis Strains
https://doi.org/10.21055/0370-1069-2012-3-61-63
Abstract
in vivo. Different forms of lipopolysaccharide (LPS) of vaccine (EV 76) and virulent (231)
Y. pestis strains, grown at 28 and 37 °C, and LPS of S- and R-chemotypes of
Escherichia coli were injected to the white mice in different combinations. Determined is the fact that primary and repeated injection of plague microbe LPS preparations in any combinations results in suppression of inflammatory response regardless of the differences in the LPS structure. In case of combined administration of
Y. pestis LPS and
E. coli LPS, the response depends on the LPS form and can vary from complete or partial tolerance to its total absence.
About the Authors
G. V. DemidovaRussian Federation
V. P. Zyuzina
Russian Federation
E. P. Sokolova
Russian Federation
N. I. Pasyukova
Russian Federation
I. A. Bespalova
Russian Federation
T. N. Borodina
Russian Federation
V. I. Tynyanova
Russian Federation
References
1. Demidova G.V., Zyuzina V.P., Sokolova E.P., Borodina T.N., Bespalova I.A., Pasyukova N.I. et al. [Toxicity of Yersinia pestis EV 76 li- popolysaccharides for mice sensitized by D galactosamine]. Zh. Microbiol. Epidemiol. Immunobiol. 2011; 1:74–6.
2. Dalpke A., Lehner M. D., Hartung T., Heeg K. Differential effects of CpG-DNA in Toll-like receptor-2/-4/-9 tolerance and cross-tolerance. Immunology. 2005; 116:203–12.
3. Kawahara K., Tsukano H., Watanabe H., Matsuura M. Modification of the structure and activity of lipid A in Yersinia pestis lipopolysaccharide by growth temperature. Infect. Immun. 2002; 70(8):4092–8.
4. Knirel Y.A., Linder B., Vinogradov E.V., Kocharova N.A., Senchenkova S.N., Shakhutdinova R.Z. et al. Temperature dependent variations and intraspecies diversity of the structure of the lipopolysaccharides of Yersinia pestis. Biochemistry. 2005; 44:731–43.
5. Matsuura M., Takahashi H., Watanabe H., Sato S., Kawahara K. Immunomodulatory properties of Yersinia pestis lipopolysaccharides on human macrophages. Clin. Vaccine Immunol. 2010; 17(1):9–55.
6. Montminy S., Khan N., McGrath S., Walkowiez M.J., Sharp F., Conlon J.E. et al. Virulent factors of Yersinia pestis are overcome by a strong lipopolysaccharide response. Nature Immun. 2006; 7(10):1066–73.
7. Telepnev M.V., Klimpel G.R., Haithcoat J., Knirel Y.A., Anisimov A.P. Tetraacylated lipopolysaccharide of Yersinia pestis can inhibit multiple Toll-like receptor-mediated signaling pathways in human dendritic cells. J. Infect. Dis. 2009; 200(11):1694–702.
8. Westphal O., Jann K. Bacterial lipopolysaccharides extraction with phenol-water and further applications of the procedure. Methods carbohydr. Chem. 1965; 5:83–91.
Review
For citations:
Demidova G.V., Zyuzina V.P., Sokolova E.P., Pasyukova N.I., Bespalova I.A., Borodina T.N., Tynyanova V.I. In vivo Tolerance to Lipopolyssacharides of Vaccine and Virulent Yersinia pestis Strains . Problems of Particularly Dangerous Infections. 2012;(3(113)):61-63. (In Russ.) https://doi.org/10.21055/0370-1069-2012-3-61-63